Best TWAS P=4.73e-12 · Best GWAS P=8.52e-10 conditioned to 0.000836
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adipose Visceral Omentum | IRF5 | 0.16 | 0.08 | lasso | 4 | 0.08 | 8.2e-05 | 5.6 | 5.9 | 3.4e-09 | 0.32 | 0.09 | 0.78 | FALSE |
2 | GTEx | Colon Transverse | IRF5 | 0.21 | 0.22 | lasso | 4 | 0.22 | 8.0e-11 | 5.6 | 5.7 | 1.2e-08 | 0.31 | 0.07 | 0.93 | FALSE |
3 | GTEx | Esophagus Mucosa | IRF5 | 0.13 | 0.14 | lasso | 4 | 0.13 | 4.6e-09 | 5.6 | 5.6 | 2.6e-08 | 0.29 | 0.07 | 0.93 | FALSE |
4 | GTEx | Esophagus Muscularis | IRF5 | 0.21 | 0.12 | lasso | 5 | 0.11 | 3.9e-07 | 5.6 | 5.8 | 5.6e-09 | 0.32 | 0.11 | 0.88 | FALSE |
5 | GTEx | Nerve Tibial | IRF5 | 0.13 | 0.09 | enet | 10 | 0.07 | 1.2e-05 | 5.6 | 5.9 | 2.9e-09 | 0.34 | 0.08 | 0.91 | FALSE |
6 | GTEx | Skin Sun Exposed Lower leg | IRF5 | 0.10 | 0.14 | lasso | 2 | 0.12 | 1.9e-10 | 5.6 | 5.7 | 9.7e-09 | 0.32 | 0.07 | 0.93 | FALSE |
7 | GTEx | Whole Blood | IRF5 | 0.17 | 0.06 | lasso | 4 | 0.09 | 1.2e-08 | -4.6 | 5.6 | 2.2e-08 | 0.31 | 0.18 | 0.82 | FALSE |
8 | METSIM | Adipose | IRF5 | 0.05 | 0.04 | lasso | 7 | 0.04 | 2.2e-06 | 5.6 | 5.7 | 1.2e-08 | 0.38 | 0.08 | 0.92 | FALSE |
9 | ROSMAP | Brain Pre-frontal Cortex | IRF5 | 0.27 | 0.25 | bslmm | 336 | 0.25 | 7.1e-32 | -4.6 | 5.2 | 2.2e-07 | 0.33 | 0.92 | 0.08 | FALSE |
10 | The Cancer Genome Atlas | Breast Invasive Carcinoma | IRF5 | 0.10 | 0.09 | lasso | 4 | 0.08 | 1.6e-16 | 5.6 | 5.7 | 1.3e-08 | 0.30 | 0.07 | 0.93 | FALSE |
11 | The Cancer Genome Atlas | Colon Adenocarcinoma | IRF5 | 0.29 | 0.26 | enet | 6 | 0.29 | 3.1e-17 | -5.7 | 6.0 | 1.7e-09 | 0.36 | 0.05 | 0.95 | FALSE |
12 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | IRF5 | 0.14 | 0.12 | enet | 7 | 0.15 | 1.8e-16 | 5.6 | 5.5 | 4.7e-08 | 0.22 | 0.07 | 0.93 | FALSE |
13 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | IRF5 | 0.09 | 0.04 | lasso | 4 | 0.06 | 2.3e-04 | 5.6 | 5.7 | 1.2e-08 | 0.30 | 0.06 | 0.87 | FALSE |
14 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | IRF5 | 0.17 | 0.09 | enet | 6 | 0.15 | 1.8e-07 | -5.0 | 6.9 | 4.7e-12 | 0.46 | 0.14 | 0.85 | TRUE |
15 | The Cancer Genome Atlas | Lung Adenocarcinoma | IRF5 | 0.18 | 0.11 | enet | 9 | 0.14 | 1.6e-15 | 5.6 | 6.1 | 9.4e-10 | 0.34 | 0.06 | 0.94 | FALSE |
16 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | IRF5 | 0.14 | 0.15 | enet | 6 | 0.14 | 7.0e-10 | -5.7 | 6.2 | 4.5e-10 | 0.36 | 0.04 | 0.96 | FALSE |
17 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | IRF5 | 0.09 | 0.10 | lasso | 3 | 0.08 | 4.6e-04 | -5.7 | 5.8 | 7.3e-09 | 0.34 | 0.03 | 0.55 | FALSE |
18 | The Cancer Genome Atlas | Prostate Adenocarcinoma | IRF5 | 0.23 | 0.26 | lasso | 3 | 0.26 | 3.6e-27 | -5.7 | 5.9 | 3.4e-09 | 0.34 | 0.04 | 0.96 | FALSE |
19 | The Cancer Genome Atlas | Rectum Adenocarcinoma | IRF5 | 0.41 | 0.13 | blup | 33 | 0.23 | 3.5e-06 | -5.7 | 6.0 | 1.6e-09 | 0.46 | 0.04 | 0.82 | FALSE |
20 | The Cancer Genome Atlas | Thyroid Carcinoma | IRF5 | 0.22 | 0.21 | enet | 9 | 0.26 | 4.6e-25 | -5.7 | 6.6 | 5.4e-11 | 0.43 | 0.05 | 0.95 | FALSE |